Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples